AFP and hepatocellular carcinoma: The diagnostic performance of AFP and its optimal cut-off values for HCC screening are still an issue of controversy [19,20]; thus, potential diagnostic biomarkers with an improved sensitivity, such as those which include extracellular vesicles [21], should further be explored.